KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Exchange Rate Effect (2020 - 2024)

Inovio Pharmaceuticals' Exchange Rate Effect history spans 10 years, with the latest figure at $32403.0 for Q1 2024.

  • For Q1 2024, Exchange Rate Effect rose 1789.42% year-over-year to $32403.0; the TTM value through Dec 2024 reached $32403.0, up 926.61%, while the annual FY2024 figure was $32403.0, 926.61% up from the prior year.
  • Exchange Rate Effect for Q1 2024 was $32403.0 at Inovio Pharmaceuticals, up from $483.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $32403.0 in Q1 2024 and bottomed at -$16563.0 in Q3 2022.
  • The 5-year median for Exchange Rate Effect is -$1918.0 (2023), against an average of -$0.13.
  • The largest annual shift saw Exchange Rate Effect plummeted 696.65% in 2022 before it soared 1789.42% in 2024.
  • A 5-year view of Exchange Rate Effect shows it stood at $21021.0 in 2020, then tumbled by 134.83% to -$7321.0 in 2021, then skyrocketed by 268.65% to $12347.0 in 2022, then crashed by 96.09% to $483.0 in 2023, then soared by 6608.7% to $32403.0 in 2024.
  • Per Business Quant, the three most recent readings for INO's Exchange Rate Effect are $32403.0 (Q1 2024), $483.0 (Q4 2023), and -$2109.0 (Q3 2023).